Park Ha Biological Technology Co., Ltd. (PHH) Stock Analysis & Investment Frameworks
Park Ha Biological Technology Co., Ltd. (PHH) stock analysis on Invetso. Review Park Ha Biological Technology Co., Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Park Ha Biological Technology Co., Ltd. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Consumer Defensive
- Industry: Household & Personal Products
- Country: CN
Park Ha Biological Technology Co., Ltd. Key Financial Metrics
- Market Cap: $9.96M
- Revenue: $2.38M
- P/E Ratio: 19.25
- ROE: 38.00%
- ROIC: 30.37%
- Dividend Yield: N/A
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., an investment holding firm, is primarily engaged in the creation and development of skincare products within the People's Republic of China. The company's operations are divided into two core areas: direct product sales and a franchise service model. Under its own 'Park Ha' brand, the company offers a comprehensive selection of skincare solutions. These products cater to a spectrum of dermatological needs, ranging from fundamental physical skin protection and exfoliation to repairing the sebum film, achieving surface microecological balance, and providing anti-aging treatments. Park Ha Biological Technology distributes its merchandise to consumers through both its company-owned retail outlets and an extensive network of franchised partners. Established in 2016, the firm's main office is situated in Wuxi, PRC. It operates as a subsidiary of Xiaoqiu Holding Ltd.